Back to search

Article

Ivermectin reduces coronavirus infection <i>in vivo</i> : a mouse experimental model

2020-11-02

Abstract excerpt

SARS-CoV2 is a single strand RNA virus member of the type 2 coronavirus family, responsible for causing COVID-19 disease in humans. The objective of this study was to test the ivermectin drug in a murine model of coronavirus infection using a type 2 family RNA coronavirus similar to SARS-CoV2, the mouse hepatitis virus (MHV). BALB/cJ female mice were infected with 6,000 PFU of MHV-A59 (Group Infected; n=20) and im...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
41ac8037-68d8-5104-9980-c794700fd257
DOI
10.1101/2020.11.02.363242
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ivermectin reduces coronavirus infection <i>in vivo</i> : a mouse experimental modelDOI 10.1101/2020.11.02.363242
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCESemantic proximity
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCESemantic proximity
Research Into Potential Therapies Against COVID-19, With Focus On IvermectinSemantic proximity
Research Into Potential Therapies Against COVID-19, With Focus On IvermectinSemantic proximity
Prospective mode of action of Ivermectin: SARS-CoV-2Semantic proximity
The selective effect of Ivermectin on different human coronaviruses; in-vitro studySemantic proximity
Eleutheroside-b and e in Acanthopanax Senticosus has Anti-PRV Activity via an Enhanced Body Immune Response in VivoSemantic proximity
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19: a pilot, double-blind, placebo-controlled, randomized clinical trialSemantic proximity
Ivermectin does not protect against SARS-CoV-2 infection in the Syrian hamster modelSemantic proximity
A Randomized Controlled Trial of Ivermectin Monotherapy Versus Hydroxychloroquine, Ivermectin, and Azithromycin Combination Therapy in Covid-19 Patients in NigeriaSemantic proximity
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.Semantic proximity
Modulating Chikungunya and Mayaro virus induced disease severity in mice using low concentrations of anti-IFNAR1 antibodiesSemantic proximity
Select a neighboring publication to make it the new centre.